Abstract
Protein and ligand molecules as two separate entities appear and behave differently, but what happens when they come together and interact with each other is one of the interesting facts in modern molecular biology and molecular recognition. This interaction can be well explained with the concept of docking which in a simple way can be described as the study of how a molecule can bind to another molecule to result in a stable entity. The two binding molecules can be either a protein and a ligand or a protein and a protein. Irrespective of which two molecules are interacting, a docking process invariably includes two steps—conformational search through various algorithms and scoring or ranking. Even though prolific research has been carried out in this field, yet it is still a topic of current interest as there is a scope for improvement to rationalize binding interactions with biological function using docking program. This chapter focuses on how to set up and perform docking runs using freeware and commercial software. Most of the known docking protocols like induced fit docking, protein–protein docking, and pharmacophore-based docking have been discussed. The use of pharmacophore queries as filters in virtual screening is also demonstrated using suitable examples.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Taylor RD, Jewsbury PJ, Essex JW (2002) A review of protein-small molecule docking methods. J Comput-Aided Mol Des 16:151–166
Li H, Gao Z, Kang L et al (2006) TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res 34:W219–W224. doi:10.1093/nar/gkl114
Halperin I, Ma B, Wolfson H, Nussinov R (2002) Principles of docking: an overview of search algorithms and a guide to scoring functions. Proteins 47:409–443
Bello M, Martínez-Archundia M, Correa-Basurto J (2013) Automated docking for novel drug discovery. Expert Opin Drug Discov 8:821–834
Glide, version 5.8, Schrödinger, LLC, New York, NY, 2012
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682550.html. Accessed 20 Oct 2013
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682401.html. Accessed 20 Oct 2013
http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682402.html. Accessed 20 Oct 2013
Keith J, Ilari A, Savino C (2008) Protein structure determination by x-ray crystallography. In: Keith JM (ed) Bioinformatics, methods in molecular biology, vol 2. Humana Press, New York, pp 63–87
Schrödinger Suite (2012) Protein Preparation Wizard; Epik version 2.3, Schrödinger, LLC, New York, NY, 2012; Impact version 5.8, Schrödinger, LLC, New York, NY, 2012; Prime version 3.1, Schrödinger, LLC, New York, NY, 2012.
LigPrep, version 2.5, Schrödinger, LLC, New York, NY, 2012
http://www.ncbi.nlm.nih.gov/pccompound. Accessed 20 Oct 2013
Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785–2791
Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading. J Comput Chem 31:455–461
http://www.ebi.ac.uk/pdbsum/. Accessed 20 Oct 2013
The PyMOL Molecular Graphics System, Version 1.5.0.4 Schrödinger, LLC.
Bahm H-J (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6:61–78
Rarey M, Kramer B, Lengauer T, Klebe G (1996) A fast flexible docking method using an incremental construction algorithm. J Mol Biol 261:470–489
Kramer B, Rarey M, Lengauer T (1999) Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking. Proteins 37:228–241
Barreca ML, Iraci N, De Luca L, Chimirri A (2009) Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 Integrase Inhibitors. ChemMedChem 4:1446–1456
Schrödinger Suite (2012) Induced fit docking protocol; Glide version 5.8, Schrödinger, LLC, New York, NY, 2012; Prime version 3.1, Schrödinger, LLC, New York, NY, 2012.
Clauben H, Buning C, Rarey M, Lengauer T (2001) FlexE: efficient molecular docking considering protein structure variations. J Mol Biol 308:377–395
Hetenyi C, van der Spoel D (2002) Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci 11:1729–1737
Campbell SJ, Gold ND, Jackson RM, Westhead DR (2003) Ligand binding: functional site location, similarity and docking. Curr Opin Struct Biol 13:389–395
Sutherland JJ, Nandigam RK, Erickson JA, Vieth M (2007) Lessons in molecular recognition. 2. Assessing and improving cross-docking accuracy. J Chem Inf Model 47:2293–2302
Verdonk ML, Mortenson PN, Hall RJ et al (2008) Protein-ligand docking against non-native protein conformers. J Chem Inf Model 48:2214–2225
Wu G, Robertson DH, Brooks CL 3rd, Vieth M (2003) Detailed analysis of grid-based molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 24(13):1549–1562
McGann M (2011) FRED pose prediction and virtual screening accuracy. J Chem Inf Model 51(3):578–596
http://www.eyesopen.com/. Accessed 20 Oct 2013
Jones S, Thornton JM (1996) Principles of protein-protein interactions. Proc Natl Acad Sci U S A 93:13–20
Davis C, Harris HJ, Hu K et al (2012) In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface. Cellular Microbiol 14:1892–1903
Vincenzetti S, Pucciarelli S, Carpi FM et al (2013) Site directed mutagenesis as a tool to understand the catalytic mechanism of human cytidine deaminase. Protein Pept Lett 20:538–549
Keskin O, Ma B, Rogale K et al (2005) Protein-protein interactions: organization, cooperativity and mapping in a bottom-up systems biology approach. Phys Biol 2:S24–S35
Wendt MD (2012) Protein-Protein Interactions. doi:10.1007/978-3-642-28965-1
Villoutreix BO, Labbé CM, Lagorce D et al (2012) A leap into the chemical space of protein-protein interaction inhibitors. Curr Pharm Des 18:4648–4667
Xenarios I, Rice DW, Salwinski L et al (2000) DIP: the database of interacting proteins. Nucleic Acids Res 28:289–291. doi:10.1093/nar/28.1.289
Szklarczyk D, Franceschini A, Kuhn M et al (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39:D561–D568.
Chatr-aryamontri A, Breitkreutz BJ, Heinicke S et al (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41:D816–D823. doi:10.1093/nar/gks1158
http://string-db.org/. Accessed 20 Oct 2013
http://hexserver.loria.fr/. Accessed 20 Oct 2013
http://zdock.umassmed.edu/. Accessed 20 Oct 2013
Chen R, Li L, Weng Z (2003) ZDOCK: an initial-stage protein-docking algorithm. Proteins 52(1):80–87
Tovchigrechko A, Vakser IA (2006) GRAMM-X public web server for protein protein docking. Nucleic Acids Res 34:W310–W314
http://graylab.jhu.edu/docking/rosetta/. Accessed 20 Oct 2013
http://cluspro.bu.edu/login.php. Accessed 20 Oct 2013
Matsuzaki Y, Uchikoga N, Ohue M et al (2013) MEGADOCK 3.0: a high-performance protein-protein interaction prediction software using hybrid parallel computing for petascale supercomputing environments. Source Code Biol Med 8:18. doi:10.1186/1751-0473-8-18
Kozakov D, Brenke R, Comeau SR, Vajda S (2006) PIPER: an FFT-based proteindocking program with pairwise potentials. Proteins 65:392–406
Griffith R, Luu TTT, Garner J, Keller PA (2005) Combining structure-based drug design and pharmacophores. J Mol Graph Model 23:439–446.
Shin WJ, Seon BL (2013) Recent advances in pharmacophore modeling and its application to anti-influenza drug discovery. Expert Opin Drug Discov 8:411–426
Caporuscio F, Tafi A (2011) Pharmacophore modelling: a forty year old approach and its modern synergies. Curr Med Chem 18:2543–2553
Hecker EA, Duraiswami C, Andrea TA, Diller DJ (2002) Use of catalyst pharmacophore models for screening of large combinatorial libraries. J Chem Inf Comput Sci 42(5):1204–1211
Phase, version 3.4, Schrödinger, LLC, New York, NY, 2012
Coteron JM, Marco M, Esquivias J et al (2011) Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. J Med Chem 54:5540–5561. doi:10.1021/jm200592f
ACD/ChemSketch, version 12, Advanced Chemistry Development, Inc., Toronto, ON, Canada, http://www.acdlabs.com, 2013
Mills N (2006) ChemDraw Ultra 10.0. J Am Chem Soc 128:13649–13650
Chen IJ, Foloppe N (2008) Conformational sampling of druglike molecules with MOE and catalyst: implications for pharmacophore modeling and virtual screening. J Chem Inf Model 48:1773–1791. doi:10.1021/ci800130k
http://www.maybridge.com/default.aspx. Accessed 20 Oct 2013
http://bioinfo3d.cs.tau.ac.il/PharmaGist/. Accessed 20 Oct 2013
Schneidman-Duhovny D, Dror O, Inbar Y et al (2008) PharmaGist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res 36:W223–W228. doi:10.1093/nar/gkn187
Cavasotto CN, Orry AJW, Abagyan RA (2005) The challenge of considering receptor flexibility in ligand docking and virtual screening. Curr Comput Aided Drug Des 1:423–440
Vajda S, Hall DR, Kozakov D (2013) Sampling and scoring: a marriage made in heaven. Proteins 81:1874–1884
Seeliger D, Groot BL (2010) Conformational transitions upon ligand binding: holo structure prediction from Apo conformation. PLoS Comput Biol 6(1):e1000634
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer India
About this chapter
Cite this chapter
Karthikeyan, M., Vyas, R. (2014). Docking and Pharmacophore Modelling for Virtual Screening. In: Practical Chemoinformatics. Springer, New Delhi. https://doi.org/10.1007/978-81-322-1780-0_4
Download citation
DOI: https://doi.org/10.1007/978-81-322-1780-0_4
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-1779-4
Online ISBN: 978-81-322-1780-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)